Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Monoclonal antibodies industry 3600 synopsis
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Monoclonal Antibodies Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic and infectious diseases worldwide
3.3.1.2 Growing research and development activities
3.3.1.3 High rate of adoption and approval in the U.S. and Europe
3.3.1.4 Booming biologics market
3.3.1.5 Rising applications of monoclonal antibodies
3.3.2 Industry pitfalls and challenges
3.3.2.1 High cost of some monoclonal antibody therapeutics
3.3.2.2 Stringent regulatory framework
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Future trends in monoclonal antibody-based therapeutics
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Monoclonal Antibodies Market Estimates and Forecast, By Type (USD Million)
5.1 Key trends, by type
5.2 Fully human
5.3 Humanized
5.4 Chimeric
5.5 Other types
Chapter 6 Monoclonal Antibodies Market Estimates and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Oncology
6.3 Autoimmune diseases
6.4 Infectious diseases
6.5 Other applications
Chapter 7 Monoclonal Antibodies Market Estimates and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Specialty centers
7.4 Other end-uses
Chapter 8 Monoclonal Antibodies Market Estimates and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Singapore
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Kuwait
8.6.6 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.2 AbbVie Inc.
9.3 Amgen Inc.
9.4 Bristol Myers Squibb
9.5 Johnson & Johnson
9.6 Merck & Co., Inc.
9.7 Regeneron Pharmaceuticals Inc.
9.8 Novartis AG
9.9 AstraZeneca
9.10 Eli Lilly and Company
9.11 GlaxoSmithKline plc
9.12 Takeda Pharmaceutical Company Limited
